Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00502827 · ClinicalTrials.gov registry record · NA
Smoking Cessation for HIV/AIDS Patients
A NA study of Human Immunodeficiency Virus, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 706
- Enrollment target
- 2
- Study locations
NCT00502827 is a NA study of Human Immunodeficiency Virus that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 706 participants, above the 166-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (325% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT00502827, a NA study of Human Immunodeficiency Virus, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 706 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this research study is to look at treatments that may help individuals who have HIV/AIDS to stop smoking.
Conditions Studied
Interventions
- BEHAVIORAL Cell Phone Intervention
- OTHER Recommended Standard of Care
Study Locations (2)
Texas
- Thomas Street Clinic - Houston
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 706 participants |
| Start Date | 2004-01 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00502827
The ClinicalTrials.gov registry entry for NCT00502827 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 706 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 166-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (325% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 2 interventions - of which Cell Phone Intervention is the first listed.
NCT00502827 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00502827 about?
NCT00502827 is a clinical study titled "Smoking Cessation for HIV/AIDS Patients". The goal of this research study is to look at treatments that may help individuals who have HIV/AIDS to stop smoking.
What is the current status of trial NCT00502827?
This trial is currently completed. It is a NA study. The enrollment target is 706 participants. The study started on 2004-01. Estimated completion is 2015-04.
What conditions does trial NCT00502827 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus.
What interventions are being tested in trial NCT00502827?
The interventions under investigation include: Cell Phone Intervention (BEHAVIORAL), Recommended Standard of Care (OTHER).
Who is sponsoring clinical trial NCT00502827?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00502827 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
RECRUITING · NA
-
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
ACTIVE NOT RECRUITING · NA
-
Integration of Hypertension Management Into HIV Care in Nigeria
ACTIVE NOT RECRUITING · NA
-
Cross-disciplinary HIV Integrated Mental Health Support Intervention
ACTIVE NOT RECRUITING · NA
-
Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.